New data suggests that retatrutide, a dual-action medication, may represent a major improvement in weight loss . This therapy combines the actions of a GLP-1 agonist and a GIP analog, seemingly offering https://ilovebookmarking.com/story21634504/the-new-breakthrough-for-weight-control